Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
PBI-200
DRUG
2 trials
Sponsors
Pyramid Biosciences
Conditions
Brain Tumor, Primary
Desmoplastic Small Round Cell Tumor
Food Effect in Healthy Volunteers
Solid Tumor, Adult
Phase 1
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
Terminated
NCT04901806
Pyramid Biosciences
Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor, Solid Tumor, Adult
Start: 2021-07-20
End: 2023-07-26
Updated: 2024-03-28
A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200
Completed
NCT05160389
Pyramid Biosciences
Food Effect in Healthy Volunteers
Start: 2021-11-17
End: 2022-01-06
Updated: 2022-01-27
Related Papers
EXTH-80. PBI-200: IN VIVO EFFICACY OF A NOVEL, HIGHLY CNS-PENETRANT NEXT GENERATION TRK INHIBITOR
Neuro-Oncology
2021-11-02
7 citations